Refinement of prognosis and the effect of azacitidine in intermediate-risk myelodysplastic syndromes

Detalles Bibliográficos
Autores principales: Liapis, Konstantinos, Papadopoulos, Vasileios, Vrachiolias, George, Galanopoulos, Athanasios G., Papoutselis, Menelaos, Papageorgiou, Sotirios G., Diamantopoulos, Panagiotis T., Pappa, Vassiliki, Viniou, Nora-Athina, Kourakli, Alexandra, Τsokanas, Dimitris, Vassilakopoulos, Theodoros P., Hatzimichael, Eleftheria, Bouronikou, Eleni, Ximeri, Maria, Pontikoglou, Charalambos, Megalakaki, Aekaterini, Zikos, Panagiotis, Panayiotidis, Panayiotis, Dimou, Maria, Karakatsanis, Stamatis, Papaioannou, Maria, Vardi, Anna, Kontopidou, Flora, Harchalakis, Nikolaos, Adamopoulos, Ioannis, Symeonidis, Argiris, Kotsianidis, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878783/
https://www.ncbi.nlm.nih.gov/pubmed/33574231
http://dx.doi.org/10.1038/s41408-021-00424-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878783/
https://www.ncbi.nlm.nih.gov/pubmed/33574231
http://dx.doi.org/10.1038/s41408-021-00424-4

Ejemplares similares